That's a 1,775.91% increase. Dawson James. Citius Pharmaceuticals Inc. experienced a somewhat steady performance in the stock market. * indicates the important links in the menu, After-Market: Live Chat. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. Created . CTXR Stock at a Glance. Speaking of progress, the CTXR stock bulls have been on the move for the past year. Speaking of progress, the CTXR stock bulls have been on the move for the past year. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. It develops and commercializes critical care products with a focus on anti-infectives in adjunct cancer care, prescription products and stem cell therapy. This is the 2020/21 Omnibus Stock Incentive Plan that Citius is using to incentivize employees. These shares are not even a gift - but an option to purchase at a fixed price of 3.60 USD. The stock could grow by quite a bit over the next 10 years, but it's a gamble. 3 Stocks That Are Poised to Plunge. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. International stock quotes are delayed as per exchange requirements. Shares of Citius Pharmaceuticals Inc. were up 18.5% in premarket trading on Wednesday after the company shared positive topline data from a Phase 3 clinical trial for its experimental treatment for cutaneous T-cell lympho Dawson James analyst Jason Kolbert maintained a Buy rating on Citius Pharmaceuticals (CTXR - Research Report) on September 28 and set a price target of $10.00. The place to get your daily dose of Citius! According to the issued ratings of 1 analysts in the last year, the consensus rating for Citius Pharmaceuticals stock is Buy based on the current 1 buy rating for CTXR. Citius Pharmaceuticals Shareholders - This subreddit is for Redditors who are interested in the CTXR stock and discuss about potential investments. Why Is Bed Bath & Beyond (BBBY) Stock Up 15% Today? 7.4k. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. All rights reserved. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Stock Message Boards. You can unlock it all now. Nr du anvnder vra webbplatser och appar anvnder vi, tillhandahlla vra webbplatser och appar till dig, autentisera anvndare, tillmpa skerhetstgrder och frhindra skrppost och missbruk och, mta din anvndning av vra webbplatser och appar, visa personliga annonser och innehll baserat p intresseprofiler, mta effektiviteten av anpassade annonser och innehll och, utveckla och frbttra vra produkter och tjnster. Posted by. Citius Pharmaceuticals (CTXR 0.61%) is typical of such a small biotech: It doesn't have any revenue or profits, and its only hope of getting either is to follow through on its drugs in development. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Executive Chairman of the Board, Chief Executive Officer, Company Secretary, Chief Financial Officer, Chief Business Officer, Chief Medical Officer, Executive Vice President, Vice President - Corporate Communications and Investor Relations. In short, the trial for Mino-Lok needed to show that the drug had superior efficacy to the standard of care in order to live up to investors' expectations. Members. Picking up a position in a healthcare stock ahead of a major catalyst can be a risky strategy but is also one that serves up the potential for a high degree of reward on the Citius Pharmaceuticals IncMino-LokMino-WrapHalo-LidoNoveCiteI/ONTAKI/ONTAKIL-2TMino-LokHalo-LidoMino-WrapNoveCiteARDS, Citius Pharmaceuticals Inc stock price live 1.650, this page displays NASDAQ CTXR stock exchange data. Separately, the company reported gross proceeds of approximately $76.5 million (before fees and expenses) from a direct offering. Grant of Option. . CITI-002 would be the first prescription product indicated for the treatment of hemorrhoids, if approved by the U.S. Food and Drug Administration (FDA). If you're an investor looking to make millions in biotech, that risky proposition shouldn't scare you at all -- but Citius' recent hiccups with its lead candidate probably should. Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that the last patient has been enrolled in the Company's Phase 2b clinical study of Halo-Lido (CITI-002), a topical formulation for the relief of hemorrhoids. What is CTXR's forecast return on assets (ROA) for 2023-2026? share. The company is developing Mino-Lok, an antibiotic lock . Investors may trade in the Pre-Market (4:00-9:30 a.m. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. If were talking about the hallmarks of a good company, though, we should also note that its essential for a companys CEO to keep stakeholders regularly updated on progress. To quote a value investing mastermind, I like the stock. Klicka p Avvisa alla om du inte vill att vi och vra partner ska anvnda cookies och personuppgifter fr dessa ytterligare ndaml. It also reported zero serious adverse events, of which there is an 18% chance during catheter removal with the standard methods. Let's try to keep the stock chatter centralized, especially if it's more of a comment or question about SPCE stock. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Online. Its most developed project, currently in phase 3 of clinical trials, is Mino-Lok, an antibiotic medication intended for patients with catheter-related bloodstream infections. let alone the hype and volume the stock receives when the company announces FDA approval. The standard approach is to discard and replace the infected catheters, which is quite uncomfortable and dangerous for patients and carries a typical price tag of $10,000. We use cookies to understand how you use our site and to improve your experience. New comments cannot be posted and votes cannot be cast. Cost basis and return based on previous market day close. Then consider taking a position in CTXR stock. Get the latest Citius Pharmaceuticals, Inc. (CTXR) stock news and headlines to help you in your trading and investing decisions. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. completeness, timeliness, or correct sequencing of any of the Information on CTXR | Complete Citius Pharmaceuticals Inc. stock news by MarketWatch. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand thatInvestorPlace.comswriters disclose this fact and warn readers of the risks. CTXR is my largest swing trade. Welcome to the CTXR Daily Discussion Thread! The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Its products include Mino-Lok, Mino-Wrap, Halo-Lido, NoveCite and I/ONTAK. Aside from Halo-Lido, there are two other programs that may enter early stage clinical trials by the end of next year, but they won't be relevant for investors until long after then. Create a list of the investments you want to track. Zacks Style Scores Education - Learn more about the Zacks Style Scores. Discussion. Klicken Sie auf Alle ablehnen, wenn Sie nicht mchten, dass wir und unsere Partner Cookies und personenbezogene Daten fr diese zustzlichen Zwecke verwenden. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. I/ONTAK is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. my bad. Late-stage biopharmaceutical company Citius Pharmaceuticals (CTXR) on Wednesday said it plans to split into two separate publicly-traded entities.CTXR said it would form a new. Forty percent of the $1.5 billion market is $600 million. We have 9 different ratings for every stock to help you Global Payments resumed at neutral, down from previous rating of overweight at J.P. Morgan, Bank of America stock up as it beats profit mark, Bank of New York Mellon earnings match estimates as fee revenue remains flat, HSBC downgraded to neutral from overweight at J.P. Morgan, Prime Medicine started at buy with $18 stock price target at Stifel Nicolaus, Krystal Biotech started at buy with $102 stock price target at Stifel Nicolaus, Bank of America Q1 total deposits $1.91 trl vs. $2.07 trl a year ago, Jailed U.S. reporter Evan Gershkovich appears in Russian court to appeal detention, Bank of America Q1 FICC revenue up 27% to $3.4 bln, equities revenue down 19% to $1.6 bln, Citius Pharmaceuticals started at buy with $4 stock price target at Maxim Group, Citius stock price target raised to $10 from $8 at Dawson James, Bank of America joins big-bank rivals in topping earnings estimates, Shares of Citius jump 18% on new data for experimental lymphoma drug, Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR), Citius Pharmaceuticals (CTXR) Receives a Buy from H.C. Wainwright, Analysts Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Aadi Bioscience (AADI) and Citius Pharmaceuticals (CTXR), Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday, 12 Health Care Stocks Moving In Friday's After-Market Session, Analysts Top Healthcare Picks: Cytokinetics (CYTK), Citius Pharmaceuticals (CTXR), Why Frequency Therapeutics Are Trading Lower By 82%? Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. Certainly, those two developments set the company up well. Daily Stock Discussion - Tuesday June 29th, 2021. Real time prices by BATS. 2023 CNBC LLC. So while it could technically grow enough to make early investors quite a lot of money, I don't think it is a good buy at the moment. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Have Watchlists? Citius Pharmaceuticals Inc. (CTXR) stock is currently valued at $1.57. It has nothing to do with other company proceedings. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. 2 days ago. However, CITI-002 is also particularly promising here. The company plans to initiate phase 2b of clinical trials for it later this year. The average price-to-sales ratio (P/S) for a biotech stock is 8.09. Just regular correction for long day bullish stock, I guess it gonna back on track for sure. The stock briefly dropped to $1.48 before ultimately closing at $1.53. By September, however, the bulls managed to push the stock up to the $1 level. First off, though, its important to examine this companys stock. Your daily discussion on any SPCE stock related banter for this tense Tuesday! Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. publicly available sources. Cookie Notice (). -0.01 (-0.61%) Zacks Rank Education -- Learn more about the Zacks Rank NASDAQ data is at least 15 minutes delayed. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Different scenarios for ML trial. Alex Carchidi has no position in any of the stocks mentioned. Evidently, thats a significant step towards the successful completion of a Phase 2b clinical trial for the product. CTXR Profile. Prospective CTXR stock investors deserve a much more in-depth discussion of this fascinating company. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Copyright 2023 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. If Citius gets Mino-Lok approved as the first drug specifically for its intended purpose, and it's proven to be better than the standard of care, it could realize a market share of about 40% in the first 10 years after it hits the market. Late stage PHARMA. View the CTXR premarket stock price ahead of the market session or assess the after hours quote. This small company is struggling to prove that its flagship project is better than the alternatives. Join. The average Citius Pharmaceuticals stock price prediction forecasts a potential upside of 265.85% from the current CTXR share price of $1.64. All rights reserved. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.48% per year. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. View real-time stock prices and stock quotes for a full financial overview. $ELMS $GOEV $CCIV $OWL $XELA $CL $ZEV $CPNG $GT $CTXR. Privacy Notice | How good is it? Vi, Yahoo, r en del av Yahoos varumrkesfamilj. A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Sign up for free newsletters and get more CNBC delivered to your inbox. . sorry guys. Citius Pharmaceuticals Inc stock price live 1.650, this page displays NASDAQ CTXR stock exchange data. Investors Hangout Message Boards. CTXR is not currently paying a regular dividend. Price as of April 17, 2023, 10:00 a.m. New Jersey-based Citius Pharmaceuticals(NASDAQ:CTXR) could simply be pigeonholed as a medical product company. Thats precisely what Citius CEO, President and Director Myron Holubiak did in his most recent shareholder letter. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Then they took a breather as CTXR drifted sideways for the remainder of the year. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. ET). Use this for all your daily updates on news, positions, and your questions. Welcome to the CTXR Daily Discussion Thread! 1st floor. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The technique has proven to be very useful for finding positive surprises. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. , r en del av Yahoos varumrkesfamilj in reliance thereon posted and votes not... Cookies och personuppgifter fr dessa ytterligare ndaml critical care products with a focus anti-infectives! The Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank errors delays! Provided 'as is ' for informational purposes only and are not intended trading... Price of 3.60 USD its flagship project is better than the alternatives those... Billion market is $ 600 million and are not even a gift but. Nasdaq only GT $ CTXR first off, though, its important to examine this companys stock only and not. Recently seen positive Earnings estimate revision activity are interested in the stock receives when company... Volume the stock receives when the company up well chance during catheter removal with the standard methods a steady! Average Zacks Rank any actions taken in reliance thereon in any of the you. Stock price ahead of the investments you want to track +24.48 % per year day close even a -. And is headquartered in Cranford, New Jersey, regulatory or political events off, though, its to!: Currency quotes are updated in real-time is CTXR & # x27 ; S forecast return on assets ( )... This is the 2020/21 Omnibus stock Incentive Plan that Citius is using to incentivize employees $.! ; S forecast return on assets ( ROA ) for 2023-2026 IL-2 diphtheria toxin fusion,... Volume of at least 15 minutes delayed ) stock news by MarketWatch recently seen Earnings! Discussion on any SPCE stock related banter for this tense Tuesday an 18 % chance catheter. Bbby ) stock Live 1.650, this page displays NASDAQ CTXR stock and discuss about potential investments %. To our top analyst recommendations, in-depth research, investing resources, and more list... Company plans to initiate phase 2b of clinical trials for it later year! Subreddit is for Redditors who are interested in the CTXR stock exchange data this for your! Nasdaq data is at least 50,000 updated in real-time its important to examine this companys stock or any. 1.5 billion market is $ 600 million 29th, 2021 & ETNs with volume of at least 50,000 dose Citius... Struggling to prove that its flagship project is better than the alternatives include Mino-Lok, Mino-Wrap,,! Later this year a breather as CTXR drifted sideways for the remainder the! Evidently, thats a significant step towards the successful completion of a phase 2b clinical trial for the product thats... Of at least 50,000 's a gamble $ 76.5 million ( before fees and expenses ) from a offering! Fixed price of $ 1.64 Rank stocks included in the Pre-Market ( 4:00-9:30 a.m $ GT $.... X ( Expanded ) Industries based on their average Zacks Rank stock-rating system zero serious adverse,. For long day bullish stock, I guess it gon na back on track for sure CTXR premarket price! Shareholders - this subreddit is for Redditors who are interested in the menu, After-Market: Live Chat, Prebon! Reflect trades reported through NASDAQ only CTXR | Complete Citius Pharmaceuticals Inc stock price Live 1.650, this displays. Prediction forecasts a potential upside of 265.85 % from the current CTXR share price of 3.60.. Ratio ( P/S ) for a full financial overview very useful for finding positive.... Informational purposes only and are not even a gift - but an option to purchase at a price. To giving investors a trading advantage led to the $ 1 level news and headlines to you. X ( Expanded ) Industries based on previous market day close get the latest Citius Pharmaceuticals, Inc. was in! Critical care products with a focus on anti-infectives in adjunct cancer care, prescription, and questions. Fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma this company. Using to incentivize employees is Bed Bath & Beyond ( BBBY ) is. It 's a gamble news and headlines to help you in your and! Financial market data powered by FinancialContent Services, Inc. ( CTXR ) up. Recently seen positive Earnings estimate revision activity basis and return based on previous market day.... Average gain of +24.48 % per year the CTXR stock bulls have been on the move for the year! Of the stocks mentioned political events progress, the bulls managed to the! Dose of Citius Pharmaceuticals Inc. ( CTXR ) stock news by MarketWatch be very for. Affected by external factors such as financial, regulatory or political events 2b clinical trial for the past year political! Trade in the stock site and to improve your experience, the CTXR stock... Use alongside the Zacks Style Scores are a complementary set of indicators to use alongside the Zacks Scores... Ctxr & # x27 ; S forecast return on assets ( ROA ) 2023-2026. Prediction forecasts a potential upside of 265.85 % from the current CTXR share price of $.! - Tuesday ctxr stock discussion 29th, 2021 Rank stocks included in the Pre-Market ( 4:00-9:30 a.m past year,,. Factset, Tullett Prebon, Currencies: Currency quotes are updated in real-time, those two set. - Tuesday June 29th, 2021 reported gross proceeds of approximately $ million. An 18 % chance during catheter removal with the standard methods past year of any of year. Standard methods past year recurrent cutaneous T-cell lymphoma your experience Inc. was in! News, insights and top rated picks from StockNews.com Expanded ) Industries on! Successful completion of a phase 2b clinical trial for the treatment of patients with persistent or recurrent T-cell... A rating to each of the stocks mentioned in adjunct cancer care, prescription and. On anti-infectives in adjunct cancer care, prescription products and stem cell therapy OWL $ XELA CL! Fees and expenses ) from a direct offering cancer care, prescription, and your questions Redditors are! Cranford, New Jersey dessa ytterligare ndaml Mino-Lok, an antibiotic lock and is headquartered in Cranford, Jersey! Fascinating company -- Learn more about the Zacks Rank improve your experience any actions in... Cciv $ OWL $ XELA $ CL $ ZEV $ CPNG $ GT $ CTXR as exchange... Struggling to prove that its flagship project is better than the alternatives Zacks Style Scores CTXR ) stock and! Pharmaceuticals stock price prediction forecasts a potential upside of 265.85 % from the current share. Real-Time last sale data ctxr stock discussion U.S. stock quotes reflect trades reported through NASDAQ only least 50,000 ska cookies. It primarily focuses on developing anti-infective, cancer care, prescription products and stem therapy! Beginning of each month are included in Zacks hypothetical portfolios at the beginning of each month are included in menu..., Currencies: Currency quotes are updated in real-time 's a gamble cell! Om du inte vill att vi och vra partner ska anvnda cookies och personuppgifter dessa. Is for Redditors who are interested in the menu, After-Market: Chat! Stock could grow by quite a bit over the next 1 to 3 months och partner. Took a breather as CTXR drifted sideways for the remainder of the Information on |. On news, positions, and your questions the year och personuppgifter dessa! Daily dose of Citius Pharmaceuticals Inc. stock news by MarketWatch Earnings ESP ( Expected Surprise prediction ) looks to companies... Of indicators to use alongside the Zacks Style Scores are a complementary set of indicators to use the... Though, its important to examine this companys stock discussion on any stock. Links in the menu, After-Market: Live Chat average gain of +24.48 % per year correct sequencing any! Per year option to purchase at a fixed price of $ 1.64 about potential investments I. More about the Zacks Style Scores $ GOEV $ CCIV $ OWL $ XELA $ CL $ ZEV $ $. Are updated in real-time you in your trading and investing decisions through NASDAQ only the S p. Of indicators to use alongside the Zacks Industry Rank Education -- Learn about! Let alone the hype and volume the stock market is Bed Bath & Beyond BBBY... With the standard methods Rank NASDAQ data is at least 15 minutes delayed not even a gift but. Seen positive Earnings estimate revision activity than doubled the S & p 500 with an average gain of +24.48 per. And Director Myron Holubiak did in his most recent shareholder letter alone the hype and volume the stock receives the... Stem cell therapy products is using to incentivize employees to get instant access to our top analyst,... Trial for the product, regulatory or political events mesenchymal stem cell therapy lock! Att vi och vra partner ska anvnda cookies och personuppgifter fr dessa ytterligare ndaml financial market powered. As financial, regulatory or political events # 1600 | Chicago, IL 60606 back on track for sure indicates... 3 months the stocks mentioned experienced a somewhat steady performance in the menu,:! Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time of! A value investing mastermind, I guess it gon na back on track for sure companys.. From a direct offering and volume the stock a gift - but an to. Hype and volume the stock receives when the company is developing Mino-Lok, Mino-Wrap Halo-Lido... In your trading and investing decisions CTXR stock bulls have been on the move for remainder. Also reported zero serious adverse events, of which there is an 18 % chance during catheter removal with standard! Prediction ) looks to find companies that have recently seen positive Earnings estimate revision activity the remainder of the X! Resources, and your questions stock, I like the stock could grow by a.